Oligonucleotides services
Syngene’s services encompass therapeutic oligonucleotides, diagnostic oligonucleotides, enzymatic synthesis, and analytical services.
Formulation Development Center (FDC): Oral Small-Molecule Drug Product Development & Manufacturing
Discover how Syngene accelerates oral and complex formulations through integrated DS‑DP‑Analytical workflows and advanced enabling technologies like SDD, HME, and nanosuspensions. Read how our GMP facilities, digital QA systems, and proven scale‑up expertise drive faster FIH and late‑phase readiness.
Clinical Development services
Syngene supports early-phase to late-phase clinical trials required for drug development programs across a wide range of therapeutic areas.
Commercial Manufacturing services
Syngene supports manufacturing of regulatory starting materials, APIs, HPAPI, NCEs and novel advanced intermediates
Your one-stop-shop for Biologics
Syngene helps biopharma companies accelerate large molecule therapies to market through integrated biologics CDMO services, with manufacturing facilities across the U.S. and India. With a GMP capacity of 50 KL in single-use bioreactors, featuring 500 L, 2000 L and 4000 L units designed to deliver economies of scale, Syngene offers innovative, flexible, and efficient solutions […]